Skip to content

Comparative Evaluation of Implant Stability, Soft & Hard Tissue Healing Around UV Activated vs Conventional Implants

Comparative Evaluation of Implant Stability, Soft and Hard Tissue Healing Around UV Activated Versus Conventional Implants - A Randomized Clinical Trial.

Status
Recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06541912
Enrollment
12
Registered
2024-08-07
Start date
2024-02-15
Completion date
2026-03-25
Last updated
2024-08-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

UV Dental Implant

Keywords

Dental Implants

Brief summary

Research is to compare and evaluate the primary and secondary implant stability, healing of the soft tissue around UV activated implants and conventional implants.

Detailed description

Research is to compare and evaluate the primary and secondary implant stability, healing of the soft tissue around UV activated implants and conventional implants. The objectives are to access the primary and secondary implant stability using Resonance frequency analysis, marginal bone level using RVG with grid, healing of the soft tissue. The control group will be treated with conventional implant and test group will be treated with UV implants. The total number of participants are 12 and 24 sites (control - 12 sites, test - 12 sites) with 3 months follow up.

Interventions

A full thickness mucoperiosteal flap was elevated under local anesthesia, osteotomy sites were prepared according to manufacturer's instructions and parallel pin was used to confirm position and angulation of osteotomy site. Conventional implant placement was done on one side. Resonance frequency analysis instrument was used to measure Implant Stability Quotient (ISQ) and check the primary stability of the implant. The surgical wound closure was done with mattress and single interrupted sutures, using 4-0 vicryl sutures.

PROCEDUREUV implant

A full thickness mucoperiosteal flap was elevated under local anesthesia and osteotomy sites were prepared according to manufacturer's instructions. Parallel pin was used to confirm position and angulation of osteotomy site. UV implant was activated using UV Activator2 and placed in another site. Resonance frequency analysis instrument was used to measure Implant Stability Quotient (ISQ) and primary stability of the implant was measured. The surgical wound closure was done with mattress and single interrupted sutures, using 4-0 vicryl sutures.

Sponsors

Krishnadevaraya College of Dental Sciences & Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* At east above 18 years of age * Patients who needs replacement for at least 2 missing teeth in the posterior region of mandible * Adequate bone volume to accommodate planned dental implants * Patients who will comply with oral health care instructions and necessary visits

Exclusion criteria

* General contraindications to dental implant treatment ( uncontrolled diabetes, severe cardiovascular or infectious disease) * Intravenous and oral bisphosphonate therapy * Unwillingness to return for the follow up examinations * Smokers * Patients who are psychologically unable to participate * Poor oral hygiene

Design outcomes

Primary

MeasureTime frameDescription
Implant stability using Resonance Frequency AnalysisImmediately after Post-operative, 1 month, 3 monthsto measure primary and secondary stability

Secondary

MeasureTime frameDescription
Marginal bone loss using RVG with gridImmediately after Post-operative, 3 monthsto measure marginal bone level
Soft tissue healing1 week, 1 month, 3 months.soft tissue healing to be assessed using Landry Turnbull and Howley Healing Index. Soft tissue healing will be scored from 1 to 5, where score 1 is very poor and 5 is excellent.

Countries

India

Contacts

Primary ContactDr. PRABHUJI MLV, MDS
prabhujimlv@gmail.com9448057407
Backup ContactDr. shailja dutta, mds
shailjadutta31@gmail.com7624845840

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026